发明名称 Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof
摘要 A preparation of a kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution containing ginsenoside Rg3 0.5˜10 mg/ml: add 0.1-5% of ginsenoside solution to 0.1˜30% of adjuvant A, B{circle around (1)}{circle around (2)}{circle around (5)} at the temperature of 40˜100° C., the ratio of these two is 1:1˜300, add water after the solvent is recycled under reduced pressure; another kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution contains 0.1˜2 mg/ml of 20 (R) of the ginsenoside Rg3, the preparation: add 0.1˜5% of ginsenoside solution to 20˜65% of adjuvant B{circle around (3)}{circle around (4)} at the temperature of 60˜100° C., main material to adjuvant B=1:100˜400, add water after the solvent is recycled under reduced pressure. The above 20 (R) ginsenoside Rg3 composition aqueous solution and the powder after lyophilization can be used to prepare injectable, oral administration and external use, and the bioactivity of these preparations is high, and with the actions of anti cancer, efficacy potentiation and toxicity attenuation effects of the combined chemical or radiation therapy of tumor, enhancement of human immune functions, improvement of human memory, anti fatigue, and detumescence, pain relieving.
申请公布号 US9333215(B2) 申请公布日期 2016.05.10
申请号 US201313941106 申请日期 2013.07.12
申请人 Fu Li 发明人 Fu Li;Lu Qi
分类号 A61K31/704;A61K9/00;A61K9/08;A61K9/19;A61K47/40;A61K47/48;B82Y5/00 主分类号 A61K31/704
代理机构 Squire Patton Boggs (US) LLP 代理人 Squire Patton Boggs (US) LLP
主权项 1. An aqueous solution of a medicinal composition comprising a 20(R)-ginsenoside Rg3, wherein the solution consists of 20(R)-ginsenoside Rg3, arginine, and water, wherein the content of the ginsenoside Rg3 in the solution is 0.5˜10 mg/ml, and the weight ratio of the 20(R)-ginsenoside Rg3 to the arginine is 1:1˜300.
地址 Dalian CN